Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE53.2400
- TODAY'S CHANGE (%)-0.7200 (-1.3343%)
- Bid / Lots51.6900/ 1
- Ask / Lots54.9400/ 1
- Open / Previous Close54.2000 / 53.9600
- Day Range
- 52 Week Range
- Volume308,213
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 1672 | 54.2 |
| 09:50 ET | 400 | 53.74 |
| 09:52 ET | 300 | 53.67 |
| 09:57 ET | 200 | 53.89 |
| 10:06 ET | 100 | 53.77 |
| 10:10 ET | 200 | 53.588 |
| 10:14 ET | 500 | 53.565 |
| 10:15 ET | 650 | 53.565 |
| 10:17 ET | 3283 | 53.51 |
| 10:19 ET | 300 | 53.52 |
| 10:21 ET | 300 | 53.32 |
| 10:24 ET | 400 | 53.4 |
| 10:26 ET | 200 | 53.49 |
| 10:28 ET | 100 | 53.64 |
| 10:33 ET | 200 | 53.44 |
| 10:35 ET | 1454 | 53.318 |
| 10:37 ET | 1228 | 53.67 |
| 10:39 ET | 100 | 53.705 |
| 10:44 ET | 100 | 53.66 |
| 10:46 ET | 318 | 53.705 |
| 10:53 ET | 300 | 53.625 |
| 10:57 ET | 100 | 53.645 |
| 11:00 ET | 200 | 53.59 |
| 11:02 ET | 200 | 53.6 |
| 11:04 ET | 100 | 53.72 |
| 11:08 ET | 100 | 53.7 |
| 11:09 ET | 5334 | 53.66 |
| 11:11 ET | 100 | 53.66 |
| 11:18 ET | 700 | 53.67 |
| 11:20 ET | 403 | 53.63 |
| 11:22 ET | 2273 | 53.56 |
| 11:24 ET | 100 | 53.6 |
| 11:26 ET | 100 | 53.54 |
| 11:27 ET | 100 | 53.6025 |
| 11:29 ET | 1401 | 53.61 |
| 11:31 ET | 1801 | 53.56 |
| 11:33 ET | 600 | 53.665 |
| 11:36 ET | 200 | 53.53 |
| 11:38 ET | 400 | 53.565 |
| 11:40 ET | 367 | 53.6 |
| 11:42 ET | 900 | 53.63 |
| 11:44 ET | 300 | 53.58 |
| 11:45 ET | 2181 | 53.44 |
| 11:49 ET | 100 | 53.425 |
| 11:51 ET | 600 | 53.34 |
| 11:54 ET | 803 | 53.39 |
| 11:56 ET | 200 | 53.36 |
| 11:58 ET | 314 | 53.44 |
| 12:00 ET | 1200 | 53.6 |
| 12:02 ET | 200 | 53.6 |
| 12:03 ET | 666 | 53.68 |
| 12:05 ET | 500 | 53.65 |
| 12:07 ET | 2200 | 53.7 |
| 12:12 ET | 2152 | 53.61 |
| 12:14 ET | 300 | 53.595 |
| 12:16 ET | 200 | 53.59 |
| 12:18 ET | 100 | 53.59 |
| 12:20 ET | 100 | 53.54 |
| 12:21 ET | 100 | 53.58 |
| 12:23 ET | 230 | 53.675 |
| 12:25 ET | 1100 | 53.68 |
| 12:27 ET | 100 | 53.675 |
| 12:30 ET | 100 | 53.67 |
| 12:32 ET | 700 | 53.655 |
| 12:36 ET | 600 | 53.625 |
| 12:38 ET | 1100 | 53.645 |
| 12:41 ET | 500 | 53.745 |
| 12:43 ET | 300 | 53.66 |
| 12:45 ET | 905 | 53.71 |
| 12:48 ET | 600 | 53.585 |
| 12:50 ET | 935 | 53.555 |
| 12:52 ET | 400 | 53.51 |
| 12:56 ET | 100 | 53.33 |
| 12:59 ET | 200 | 53.305 |
| 01:01 ET | 400 | 53.2 |
| 01:03 ET | 200 | 53.04 |
| 01:06 ET | 100 | 53.007 |
| 01:10 ET | 1452 | 53.075 |
| 01:12 ET | 481 | 53.075 |
| 01:14 ET | 900 | 53.19 |
| 01:26 ET | 300 | 53.17 |
| 01:28 ET | 300 | 53.13 |
| 01:32 ET | 300 | 53.09 |
| 01:33 ET | 800 | 53.025 |
| 01:35 ET | 500 | 53.07 |
| 01:39 ET | 100 | 53.08 |
| 01:42 ET | 1326 | 53.05 |
| 01:44 ET | 800 | 53.11 |
| 01:48 ET | 100 | 53.11 |
| 01:50 ET | 400 | 52.99 |
| 01:53 ET | 100 | 52.92 |
| 01:55 ET | 1916 | 52.93 |
| 02:02 ET | 215 | 52.88 |
| 02:06 ET | 200 | 52.96 |
| 02:08 ET | 200 | 52.9397 |
| 02:11 ET | 500 | 53 |
| 02:13 ET | 500 | 52.88 |
| 02:15 ET | 300 | 52.875 |
| 02:18 ET | 500 | 52.93 |
| 02:20 ET | 200 | 52.95 |
| 02:22 ET | 300 | 52.95 |
| 02:24 ET | 100 | 52.93 |
| 02:26 ET | 300 | 52.9 |
| 02:27 ET | 325 | 52.84 |
| 02:29 ET | 300 | 52.87 |
| 02:31 ET | 400 | 52.98 |
| 02:33 ET | 200 | 53.06 |
| 02:36 ET | 100 | 53.12 |
| 02:38 ET | 781 | 53.05 |
| 02:40 ET | 100 | 53 |
| 02:42 ET | 300 | 52.975 |
| 02:45 ET | 200 | 53.07 |
| 02:51 ET | 300 | 53.11 |
| 02:54 ET | 300 | 53.15 |
| 02:56 ET | 200 | 53.08 |
| 02:58 ET | 200 | 53.07 |
| 03:00 ET | 467 | 53.13 |
| 03:02 ET | 300 | 53.09 |
| 03:03 ET | 338 | 53.175 |
| 03:05 ET | 300 | 53.17 |
| 03:07 ET | 100 | 53.15 |
| 03:12 ET | 1000 | 53.08 |
| 03:14 ET | 1200 | 53.18 |
| 03:16 ET | 318 | 53.175 |
| 03:18 ET | 400 | 53.22 |
| 03:20 ET | 100 | 53.2 |
| 03:21 ET | 100 | 53.17 |
| 03:23 ET | 500 | 53.1 |
| 03:27 ET | 1024 | 53.08 |
| 03:30 ET | 225 | 53.065 |
| 03:32 ET | 309 | 53.09 |
| 03:34 ET | 2317 | 53.14 |
| 03:36 ET | 215 | 53.07 |
| 03:38 ET | 2079 | 53.04 |
| 03:39 ET | 600 | 53.085 |
| 03:41 ET | 700 | 53 |
| 03:43 ET | 300 | 52.96 |
| 03:45 ET | 5200 | 53.15 |
| 03:48 ET | 1765 | 53.16 |
| 03:50 ET | 500 | 53.23 |
| 03:52 ET | 2388 | 53.265 |
| 03:54 ET | 3184 | 53.085 |
| 03:56 ET | 4259 | 52.99 |
| 03:57 ET | 3894 | 53.03 |
| 03:59 ET | 106949 | 53.24 |
Aug 12, 2024
Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Monday Aug 12, 2024 by Dow Jones
4:05PM ET on Monday Aug 12, 2024 by Dow Jones
Aug 9, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co., from 5:08PM ET on Friday Aug 09, 2024 by Dow Jones
5:08PM ET on Friday Aug 09, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Cut to $73.00/Share From $74.00 by Oppenheimer, from 11:30AM ET on Friday Aug 09, 2024 by Dow Jones
11:30AM ET on Friday Aug 09, 2024 by Dow Jones
Aug 8, 2024
*DJ Crinetics Pharmaceuticals 2Q Loss/Shr 94c >CRNX, from 4:05PM ET on Thursday Aug 08, 2024 by Dow Jones
4:05PM ET on Thursday Aug 08, 2024 by Dow JonesCrinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Thursday Aug 08, 2024 by Dow Jones
4:05PM ET on Thursday Aug 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.3B | -14.1x | --- |
Dyne Therapeutics Inc | 4.7B | -12.7x | --- |
Biohaven Ltd | 3.9B | -4.4x | --- |
Immunovant Inc | 4.8B | -16.4x | --- |
BridgeBio Pharma Inc | 4.8B | -9.4x | --- |
Iovance Biotherapeutics Inc | 3.6B | -6.9x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.3B |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.64 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -14.1x |
Price/Sales (TTM) | 3,118.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
